TheRightDoctors Logo
Pre Alpha
Insights from the World's Best Medical Minds
nine

Pharmacoinvasive approach for STEMI management is the ideal for Indian scenario

Tenecteplase is better 3rd generation thrombolytic agent because of a single bolus injection hence ease of administration, higher fibrin specificity and no antigenicity
Pause
Love It
Download

Dr.Annapoorna A Kalia

Interventional Cardiologist

Aditya Birla Memorial Hospital, Pune


"Tenecteplase is better 3rd generation thrombolytic agent because of a single bolus injection hence ease of administration, higher fibrin specificity and no antigenicity" Dr.Annapoorna Kalia, Emcure CSI tv

Mail us at editorial@therightdoctors.com. Stay updated on Facebook , Twitter , You Tube and LinkedIn.



Join TheRightDoctors on WhatsApp. Type "JOIN" and send to 9676401536